Based on information from “The Cancer Genome Atlas,” the expression of SLFN13 is reduced in pulmonary squamous cell cancer and rectal cancer, but increased in pancreatic adenocarcinoma and krenal cell cancer (57). Here, SLFN13 is linked to cancer.